BET inhibitor

Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Fri, 04/12/24 - 11:23 am
Novartis
MorphoSys
pelabresib
myelofibrosis
M&A
BET inhibitor
Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
CP Wire
Thu, 04/12/18 - 11:59 am
melanoma
Wistar Institute
BET inhibitor
MEK inhibitor
Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
Thu, 04/12/18 - 11:56 am
melanoma
MEK inhibitor
BET inhibitor